• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

偶然Lewy 体与前驱帕金森病的神经病理学。

Neuropathology of incidental Lewy body & prodromal Parkinson's disease.

机构信息

Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.

Department of Translational Brain Research, DZNE-German Center for Neurodegenerative Diseases, 81377, Munich, Germany.

出版信息

Mol Neurodegener. 2023 May 12;18(1):32. doi: 10.1186/s13024-023-00622-7.

DOI:10.1186/s13024-023-00622-7
PMID:37173733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10182593/
Abstract

BACKGROUND

Parkinson's disease (PD) is a progressive neurodegenerative disorder associated with a loss of dopaminergic (DA) neurons. Despite symptomatic therapies, there is currently no disease-modifying treatment to halt neuronal loss in PD. A major hurdle for developing and testing such curative therapies results from the fact that most DA neurons are already lost at the time of the clinical diagnosis, rendering them inaccessible to therapy. Understanding the early pathological changes that precede Lewy body pathology (LBP) and cell loss in PD will likely support the identification of novel diagnostic and therapeutic strategies and help to differentiate LBP-dependent and -independent alterations. Several previous studies identified such specific molecular and cellular changes that occur prior to the appearance of Lewy bodies (LBs) in DA neurons, but a concise map of such early disease events is currently missing.

METHODS

Here, we conducted a literature review to identify and discuss the results of previous studies that investigated cases with incidental Lewy body disease (iLBD), a presumed pathological precursor of PD.

RESULTS

Collectively, our review demonstrates numerous cellular and molecular neuropathological changes occurring prior to the appearance of LBs in DA neurons.

CONCLUSIONS

Our review provides the reader with a summary of early pathological events in PD that may support the identification of novel therapeutic and diagnostic targets and aid to the development of disease-modifying strategies in PD.

摘要

背景

帕金森病(PD)是一种进行性神经退行性疾病,与多巴胺能(DA)神经元丧失有关。尽管有对症治疗,但目前尚无能够阻止 PD 神经元丧失的疾病修正治疗方法。开发和测试此类治愈疗法的主要障碍是,在临床诊断时大多数 DA 神经元已经丢失,使得它们无法进行治疗。了解在路易体病理学(LBP)和 PD 细胞丧失之前发生的早期病理变化,可能有助于确定新的诊断和治疗策略,并有助于区分 LBP 依赖性和非依赖性改变。以前的几项研究已经确定了在 DA 神经元中出现路易体(LB)之前发生的这种特定的分子和细胞变化,但目前缺乏这种早期疾病事件的简明图谱。

方法

在这里,我们进行了文献综述,以确定和讨论以前研究的结果,这些研究调查了偶发路易体病(iLBD)的病例,这是 PD 的假定病理前体。

结果

总的来说,我们的综述表明,在 DA 神经元中出现 LB 之前,就已经发生了许多细胞和分子神经病理学变化。

结论

我们的综述为读者提供了 PD 中早期病理事件的总结,这可能有助于确定新的治疗和诊断靶点,并有助于开发 PD 的疾病修正策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/447e/10182593/46a75a385d9a/13024_2023_622_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/447e/10182593/1837bc6fb5fb/13024_2023_622_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/447e/10182593/037ec404203e/13024_2023_622_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/447e/10182593/46a75a385d9a/13024_2023_622_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/447e/10182593/1837bc6fb5fb/13024_2023_622_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/447e/10182593/037ec404203e/13024_2023_622_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/447e/10182593/46a75a385d9a/13024_2023_622_Fig3_HTML.jpg

相似文献

1
Neuropathology of incidental Lewy body & prodromal Parkinson's disease.偶然Lewy 体与前驱帕金森病的神经病理学。
Mol Neurodegener. 2023 May 12;18(1):32. doi: 10.1186/s13024-023-00622-7.
2
[Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].帕金森病与路易体痴呆早期诊断的临床与病理研究
Rinsho Shinkeigaku. 2008 Jan;48(1):11-24. doi: 10.5692/clinicalneurol.48.11.
3
Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.特发性快速眼动睡眠行为障碍的神经退行性疾病状态和死后病理学:一项观察性队列研究。
Lancet Neurol. 2013 May;12(5):443-53. doi: 10.1016/S1474-4422(13)70056-5. Epub 2013 Apr 3.
4
Lewy Bodies and the Mechanisms of Neuronal Cell Death in Parkinson's Disease and Dementia with Lewy Bodies.路易小体与帕金森病和路易体痴呆中神经元细胞死亡的机制
Brain Pathol. 2017 Jan;27(1):3-12. doi: 10.1111/bpa.12344. Epub 2016 Jan 18.
5
Conjugal Synucleinopathies: A Clinicopathologic Study.配偶型突触核蛋白病:临床病理研究。
Mov Disord. 2024 Jul;39(7):1212-1217. doi: 10.1002/mds.29783. Epub 2024 Apr 10.
6
Neuropathology of Lewy body disease: Clinicopathological crosstalk between typical and atypical cases.路易体病的神经病理学:典型与非典型病例的临床病理对话。
Neuropathology. 2020 Feb;40(1):30-39. doi: 10.1111/neup.12597. Epub 2019 Sep 9.
7
The Lewy body in Parkinson's disease and related neurodegenerative disorders.路易体在帕金森病及相关神经退行性疾病中的作用。
Mol Neurobiol. 2013 Apr;47(2):495-508. doi: 10.1007/s12035-012-8280-y. Epub 2012 May 24.
8
[Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].[帕金森病、路易体痴呆、多系统萎缩与α-突触核蛋白]
Rinsho Shinkeigaku. 1999 Dec;39(12):1285-6.
9
Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?偶然发现的路易体病:一些病例是否代表了路易体痴呆的临床前期?
Neurobiol Aging. 2011 May;32(5):857-63. doi: 10.1016/j.neurobiolaging.2009.05.019. Epub 2009 Jun 26.
10
[Multi-Organ Distribution of Alpha-Synuclein Pathology in Dementia with Lewy Bodies].[路易体痴呆中α-突触核蛋白病理改变的多器官分布]
Brain Nerve. 2018 May;70(5):489-500. doi: 10.11477/mf.1416201031.

引用本文的文献

1
Novel in situ seeding immunodetection assay uncovers neuronal-driven alpha-synuclein seeding in Parkinson's disease.新型原位接种免疫检测法揭示帕金森病中神经元驱动的α-突触核蛋白种子形成。
NPJ Parkinsons Dis. 2025 Aug 25;11(1):259. doi: 10.1038/s41531-025-01111-y.
2
Recent Insights About Probiotics Related Pharmabiotics in Pharmacology: Prevention and Management of Diseases.药理学中关于益生菌相关药物生物制品的最新见解:疾病的预防与管理
Probiotics Antimicrob Proteins. 2025 Jun 23. doi: 10.1007/s12602-025-10613-3.
3
Constipation and risk of cognitive impairment and dementia in adults: a systematic review and meta-analysis.

本文引用的文献

1
Alpha Synuclein: Neurodegeneration and Inflammation.α-突触核蛋白:神经退行性变与炎症。
Int J Mol Sci. 2023 Mar 21;24(6):5914. doi: 10.3390/ijms24065914.
2
Targeting the inflammasome in Parkinson's disease.靶向帕金森病中的炎性小体。
Front Aging Neurosci. 2022 Oct 12;14:957705. doi: 10.3389/fnagi.2022.957705. eCollection 2022.
3
Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson's disease.α-突触核蛋白寡聚物与帕金森病路易体相关病理分布的差异。
成人便秘与认知障碍和痴呆风险:一项系统评价和荟萃分析。
Front Neurol. 2025 Jun 4;16:1600952. doi: 10.3389/fneur.2025.1600952. eCollection 2025.
4
T cell responses towards PINK1 and α-synuclein are elevated in prodromal Parkinson's disease.前驱期帕金森病患者对PTEN诱导激酶1(PINK1)和α-突触核蛋白的T细胞反应增强。
NPJ Parkinsons Dis. 2025 May 26;11(1):137. doi: 10.1038/s41531-025-01001-3.
5
Exosome-Mediated Mitochondrial Regulation: A Promising Therapeutic Tool for Alzheimer's Disease and Parkinson's Disease.外泌体介导的线粒体调控:治疗阿尔茨海默病和帕金森病的一种有前景的治疗工具。
Int J Nanomedicine. 2025 Apr 17;20:4903-4917. doi: 10.2147/IJN.S513816. eCollection 2025.
6
A Mendelian randomization study on association of alpha-synuclein and GPNMB with Parkinson's disease risk and progression.一项关于α-突触核蛋白和糖蛋白非转移性黑色素瘤蛋白B与帕金森病风险及进展相关性的孟德尔随机化研究。
Mol Neurobiol. 2025 Apr 11. doi: 10.1007/s12035-025-04928-z.
7
Extracellular particles: emerging insights into central nervous system diseases.细胞外颗粒:对中枢神经系统疾病的新见解
J Nanobiotechnology. 2025 Apr 1;23(1):263. doi: 10.1186/s12951-025-03354-6.
8
DRN-SNc serotonergic circuit drives stress-induced motor deficits and Parkinson's disease vulnerability.中脑导水管周围灰质-黑质致密部血清素能回路驱动应激诱导的运动缺陷和帕金森病易感性。
Neuropsychopharmacology. 2025 Jun;50(7):1051-1062. doi: 10.1038/s41386-025-02080-9. Epub 2025 Mar 17.
9
Comparing In vitro Protein Aggregation Modelling Using Strategies Relevant to Neuropathologies.使用与神经病理学相关的策略比较体外蛋白质聚集模型
Cell Mol Neurobiol. 2025 Mar 13;45(1):24. doi: 10.1007/s10571-025-01539-z.
10
Controversy and multiple roles of the solitary nucleus receptor Nur77 in disease and physiology.孤核受体Nur77在疾病与生理学中的争议及多重作用
FASEB J. 2025 Mar 31;39(6):e70468. doi: 10.1096/fj.202402775RR.
Acta Neuropathol Commun. 2022 Sep 6;10(1):133. doi: 10.1186/s40478-022-01440-6.
4
Monoclonal Antibody Therapy in Parkinson's Disease - The End?帕金森病中的单克隆抗体疗法——终结?
N Engl J Med. 2022 Aug 4;387(5):466-467. doi: 10.1056/NEJMe2207681.
5
Trial of Prasinezumab in Early-Stage Parkinson's Disease.普拉克索尼单抗治疗早期帕金森病的试验。
N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867.
6
Trial of Cinpanemab in Early Parkinson's Disease.西尼潘单抗治疗早期帕金森病的临床试验。
N Engl J Med. 2022 Aug 4;387(5):408-420. doi: 10.1056/NEJMoa2203395.
7
Association of Angiotensin Receptor Blockers with Incident Parkinson Disease in Patients with Hypertension: A Retrospective Cohort Study.血管紧张素受体阻滞剂与高血压患者帕金森病发病的相关性:一项回顾性队列研究。
Am J Med. 2022 Aug;135(8):1001-1007. doi: 10.1016/j.amjmed.2022.04.029. Epub 2022 May 14.
8
Protective Effect of Renin-Angiotensin System Inhibitors on Parkinson's Disease: A Nationwide Cohort Study.肾素-血管紧张素系统抑制剂对帕金森病的保护作用:一项全国性队列研究
Front Pharmacol. 2022 Mar 3;13:837890. doi: 10.3389/fphar.2022.837890. eCollection 2022.
9
Alpha-Synuclein defects autophagy by impairing SNAP29-mediated autophagosome-lysosome fusion.α-突触核蛋白通过损害 SNAP29 介导的自噬体-溶酶体融合来抑制自噬。
Cell Death Dis. 2021 Sep 17;12(10):854. doi: 10.1038/s41419-021-04138-0.
10
Cross-platform transcriptional profiling identifies common and distinct molecular pathologies in Lewy body diseases.跨平台转录组谱分析确定路易体病中的常见和独特分子病理学。
Acta Neuropathol. 2021 Sep;142(3):449-474. doi: 10.1007/s00401-021-02343-x. Epub 2021 Jul 26.